Skip to main content
Payam Nahid, MD, Pulmonology, San Francisco, CA, Zuckerberg San Francisco General Hospital and Trauma Center

PayamNahidMD

Pulmonology • San Francisco, CA

Critical Care Medicine, Pleural Disease

Associate Professor, Medicine, UCSF School of Medicine

Join to view full profile

Are you Dr. Nahid?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 35 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Payam Nahid, MD is a pulmonologist in San Francisco, California. He is currently licensed to practice medicine in California. He is affiliated with Zuckerberg San Francisco General Hospital and Trauma Center and is an Associate Professor at UCSF School of Medicine.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 2001 - 2004
  • Scripps Clinic/Scripps Green Hospital
    Scripps Clinic/Scripps Green HospitalResidency, Internal Medicine, 1998 - 2001
  • University of California (Irvine)
    University of California (Irvine)Internship, Internal Medicine, 1997 - 1998
  • University of California, Irvine, School of Medicine
    University of California, Irvine, School of MedicineClass of 1997

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1999 - 2024
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Pulmonary Disease

Publications & Presentations

PubMed

Press Mentions

  • UCSF Joins $200 Million Global Tuberculosis Consortium
    UCSF Joins $200 Million Global Tuberculosis ConsortiumAugust 2nd, 2022
  • Study: Four-Month Regimen of Anti-TB Drugs Works Just as Well as Standard Regimen
    Study: Four-Month Regimen of Anti-TB Drugs Works Just as Well as Standard RegimenMay 24th, 2021
  • New TB Drug Regimen Controls Resistant Disease in 9 of 10 Cases: Study
    New TB Drug Regimen Controls Resistant Disease in 9 of 10 Cases: StudyMarch 4th, 2020
  • Join now to see all

Grant Support

  • Interplay Of Strain And Ethnicity In The Immune Response To M. TuberculosisNational Heart, Lung, And Blood Institute2007–2011

Hospital Affiliations

Dr. Payam Nahid, Dr. Payam Nahid, MD, Dr. P Nahid